- Statements & Policies
- Summary of Disclosures
By accessing biotech-today.com (hereinafter referred to as “this website”) you hereby affirmatively represent to Maynard Communication Limited that you have read and understood the entirety of the following statements and policies.
If you do not agree to these Statements & Policies, you may not use the biotech-today.com website and affirmatively acknowledge that you have not used or viewed content on the biotech-today.com website.
Maynard Communication Limited is neither an investment advisor nor broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on biotech-today.com constitutes advice or a recommendation.
The opinions and analyses included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith. Maynard Communication Limited makes no representation or warranty, expressed, implied or statutory, as to the accuracy or completeness of such information, which may be subject to change without notice.
Safe Harbor Statement
This website contains forward-looking statements applicable to future anticipated performance, growth, and plans of the companies on whose behalf we disseminate information. As such, any specific statement on this website that are not statements of factual history should be viewed as forward-looking statements. These forward-looking statements can be generally identified through phrases such as “possibly”, “anticipates”, “estimates”, “potentially”, “intends”, and other words of similar connotation. Statements in this website that speak to a company’s business intentions, objectives, strategies, and or intentions should also be viewed as forward-looking statements. All forward-looking statements are subject to uncertainties that could result in different outcomes than those described in forward-looking statements.
By accessing this website, you indicate your agreement to these Statements & Policies. You affirmatively represent that you have read and understood the entirety of the following Statements & Policies. We reserve the right, at our discretion, to change, modify, and add or delete portions of such Statements & Policies at any time.
The entire contents of this site are protected by worldwide copyright laws and treaty provisions. The contents of this website are for non-commercial individual reference only and may not be used for other purposes or otherwise copied, displayed, downloaded, distributed, modified, reproduced, republished or retransmitted without the express written consent of Maynard Communication Limited.
Information subject to change
Information on this website is updated regularly by Maynard Communication Limited without notice. However, the information is not intended to be complete and cover all matters and developments concerning the company and its activities and the company cannot guarantee either the currency or completeness of the information at all times and assumes no responsibility in this regard.
All stock quotes are delayed at least 15 minutes unless otherwise noted. All stock quotes and historical stock price data are provided by a third-party service provider and are provided for information purposes only and not for trading purposes. Maynard Communication Limited makes no representation or warranty regarding the accuracy or completeness of any stock price quotes or historical stock price data and has not verified the adequacy, accuracy or completeness of the information provided on this website. We strongly recommend that you seek independent professional advice before investing in any companies and stock mentioned in the articles on the website.
Notice to investors
The information on this website is not intended as a solicitation for funds or an offering of securities and should not be construed or interpreted as such. The information on this website is not intended to modify, qualify, supplement or amend information disclosed under applicable securities legislation of the U.S. or Canada. No securities commission or other regulatory authority in either the U.S. or Canada has in any way passed upon the information on this website and Maynard Communication Limited makes no representation or warranty to that effect.
Caution to U.S. readers
This website references resources in the “Measured” “Indicated” and “Inferred” categories. These are terms defined under National Instrument 43-101 of the Canadian securities regulators. We advise U.S. investors that while these terms are recognized and required by Canadian regulations, the U.S. Securities and Exchange Commission does not recognize them. Investors are cautioned not to assume that any part or all of the material in the “Measured” or “Indicated” resource categories will ever be converted into mineral reserves. In addition, “Inferred” resources have great uncertainty as to their existence, and great uncertainty as to the economic and legal feasibility of exploiting these in a mining operation. It cannot be assumed that any part or all of an Inferred resource will ever be upgraded to a higher category. Under Canadian rules, estimates of an Inferred resource may not form the basis of pre-feasibility or feasibility studies except in rare cases. Investors are cautioned not to assume that any part or all of an Inferred resource exists or is economically or legally mineable.
Maynard Communication Limited supports the use of social media, however any third-party content posted through social media channels maintained by us should not be taken as an endorsement of such information. Links to websites and other resources operated by third parties (“Third Party Information”) other than Maynard Communication Limited are provided solely as a convenience to the user. We do not control such Third-Party Information and are not responsible and disclaim any liability for the content, products, services or information offered by any third parties. The inclusion of links to such Third-Party Information on the page does not imply endorsement of any content, products or services offered, advertised, endorsed or promoted by any third party, or of any company or person. If you decide to access any Third-Party Information or acquire any third-party products or services, you do so entirely at your own risk, and you may be subject to the terms and conditions and the privacy policies imposed by such third parties. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there can be no assurance as to the accuracy or completeness of included information. Although believed to be reliable, management of Maynard Communication Limited has not independently verified any of the data from third party sources.
Maynard Communication Limited and its owners, members, officers, directors, partners and consultants may own shares of the profiled companies, which it may sell at any time, including as soon as it deposits such shares into its trading accounts, during our campaign of the profiled companies stock, after our campaign or at any other time. We also may buy and sell securities in the profiled companies which may cause (a) decline in the price of the profiled companies stock due to our selling activities, (b) increased volatility due to our buying and selling of the profiled companies stock and (c) permit us to make substantial profits while we are profiling each of these companies, yet may result in a diminished value to the stock for investors.
A short time after we acquire a profiled company’s shares, we may publish favourable information about the profiled company advising others, including you, to consider purchasing shares of the profiled company. While doing so, we may sell the profiled company’s securities we acquired during the public dissemination causing us to profit while you suffer a loss.
Completion of a Campaign
Most, if not all, of the companies profiled by Maynard Communication Limited are penny stocks that are illiquid (they do not have much trading volume at all) and whose securities are subject to wide fluctuations in trading price and volume. During any campaign the trading volume and price of the securities of each profiled issuer will likely increase significantly. When the campaign ends, the volume and price of the profiled company will likely decrease dramatically. As a result, investors who purchase during the campaign and hold shares of the profiled company when the campaign ends will probably lose most, if not all, of their investment.
Neither Maynard Communication Limited nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment advisor or broker-dealer or associated person with a registered investment advisor or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company in the biotech-today.com website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. Therefore, information on this website is not intended to be, and shall not substitute, an offer to sell nor the solicitation of any offer to buy any security.
The opinions and analysis included in this website are related to the profiled companies represent the personal and subjective views of the author of the articles and are subject to change at any time without notice. The information provided in the articles on the website and the content has been obtained from sources which the authors believe to be reliable. However, the author has not independently verified or otherwise investigated all such information. None of the authors, Maynard Communication Limited, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The opinion, analysis, articles and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission, the Canadian security regulatory authorities, the Canadian Securities Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
Information obtained from public filings and other sources are deemed reliable; however, Maynard Communication Limited take no responsibility for verifying the accuracy of such information and makes no representation that such information is complete and correct. Maynard Communication Limited makes no representation makes no guarantee that any forward-looking statements will provide to be accurate. Persons using Maynard Communication Limited are encouraged to consult with independent financial advisors with respect to an investment in any company profiled herein. Investors should therefore verify independently information provided in the Maynard Communication Limited website by completing their due diligence on any company in which their clients are contemplating an investment. Such information to be reviewed could include the company’s annual reports, regulatory filings, and press releases on the sec.gov website or directly from the issuer.
The content published is a snapshot that provides positive information on the profiled companies. The information consists of only positive content. We do not and will not publish negative information about the profiled companies. Accordingly, investors should consider the information to be one-side and not balanced, complete, accurate, truthful or reliable.
The content published on this website is intended for and only to be used for reference purposes and is neither an offer nor a solicitation to purchase or sell any security or instrument or to participate in any particular trading strategy. No such information provided through Maynard Communication Limited constitutes advice or a recommendation that any investment or trading strategy is suitable for any specific person. Users of this website agree that they are not using any content of this website in connection with an investment decision.
THERE CAN BE NO ASSURANCE THAT CONTENTS PUBLISHED ON BIOTECH-TODAY.COM IS ACCURATE OR WITHOUT ERROR. ANY PERSON WHO MAKES USE OF SUCH CONTENT AFFIRMATIVELY ASSUMES ALL RISKS FROM USING THE CONTENT.
Maynard Communication Limited does not guarantee it reviews and is not responsible for confirming the accuracy of information submitted for inclusion on this site.
INVESTORS ARE STRONGLY ADVISED TO CONFIRM THE ACCURACY OF ANY INFORMATION OBTAINED FROM THIS SITE PRIOR TO MAKING ANY INVESTMENT DECISION.
Investors should review the profiled company’s financial condition, operations, management, products or services, trends in the industry and risk that may be material to the profiled company’s business and other information that he or his advisors deem material for an investment decision.
OTC and Microcap Risk Warnings
Because many securities traded Over-The-Counter (OTC) are relatively illiquid, or “thinly traded,” which tends to increase volatility in market prices, an investment in an OTC security involves a high degree of risk. These speculative and illiquid securities are often difficult for investors to buy or sell without significantly affecting the quoted price. It should be noted that the liquidation of a position in an OTC security may not even be possible within a reasonable period of time.
Dependable information regarding issuers of OTC securities, their prospects, or the risks associated with the business of any particular issuer or an investment in the issuer’s securities may not be available. For this reason, it may be difficult to properly value an investment in an OTC security or accurately determine the risks involved with investing in such a security. For more information about investing in microcap securities, please read the content on the SEC’s website, including the SEC’s investor publication titled “Microcap Stock: A Guide for Investors” available at https://www.sec.gov/investor/pubs/microcapstock.htm.
Issuers of OTC securities quoted on the OTC Link system are not required to provide any kind of information to investors. While many issuers register OTC securities with the Securities and Exchange Commission (SEC) and regularly provide reports to investors in connection with such registration, they are not required to continue such registration or regularly provide such reports because their securities are quoted on OTC Link. Securities may continue to be quoted on the OTC Link system if issuers are delinquent in their reporting obligation to the SEC or other federal or state regulatory agencies. Quotation of a security on the OTC Link system does not in itself create any ongoing filing or reporting obligations with the SEC for any issuer. In fact, issuers may not even be aware that their securities are quoted on the OTC Link system.
Purpose of the Disclaimer
We are providing you with this disclaimer because we are publishing advertisements about penny stocks. Because we are paid to disseminate information to the public about securities, we are required by the securities laws including Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 thereunder, and Section 17(b) of the Securities Act of 1933, as amended (the “Securities Act”), to specifically disclose my compensation as well as other important information, This information includes that we may hold, as well as purchase and sell, the securities of a profiled company before, during and after we publish favorable information about the profiled company. We may urge investors to purchase the securities of a profiled company while we sell my own shares.
The anti-fraud provisions of federal and state securities laws require us to inform you that we may engage in buying and selling of profiled company’s securities before, during and after our campaigns.
When a campaign ends, the stock price of a profiled company will decline.